Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin CohortCapsule Summary

Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin CohortCapsule Summary

Background: Oral Janus kinase inhibitors (JAKis) have black-box warnings of infections, cancer risk, and cardiovascular and venous thromboembolic events. They may be used off-label for chronic hand eczema (CHE). Objectives: Assess the prevalence of risk factors potentially impacting oral JAKi safety...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki M.F. Andersen, MD, PhD (Author), Johan Sieborg, MSc (Author), Lea Nymand, MSc (Author), Tiago Torres, MD, PhD (Author), Andrea Chiricozzi, MD (Author), Simon Francis Thomsen, MD, PhD, DMSc (Author), Jacob P. Thyssen, MD, PhD, DMSc (Author), Alexander Egeberg, MD, PhD, DMSc (Author)
Format: Book
Published: Elsevier, 2024-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items